IT1282673B1 - Derivati della camptotecina e loro uso come agenti antitumorali - Google Patents

Derivati della camptotecina e loro uso come agenti antitumorali

Info

Publication number
IT1282673B1
IT1282673B1 IT96MI000338A ITMI960338A IT1282673B1 IT 1282673 B1 IT1282673 B1 IT 1282673B1 IT 96MI000338 A IT96MI000338 A IT 96MI000338A IT MI960338 A ITMI960338 A IT MI960338A IT 1282673 B1 IT1282673 B1 IT 1282673B1
Authority
IT
Italy
Prior art keywords
pct
cancer agents
date aug
derivatives
camptotecin
Prior art date
Application number
IT96MI000338A
Other languages
English (en)
Italian (it)
Inventor
Lucio Merlini
Sergio Penco
Franco Zunino
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1282673(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Priority to IT96MI000338A priority Critical patent/IT1282673B1/it
Publication of ITMI960338A0 publication Critical patent/ITMI960338A0/it
Priority to JP52979197A priority patent/JP4171527B2/ja
Priority to CN97192493A priority patent/CN1107677C/zh
Priority to US09/125,512 priority patent/US6130227A/en
Priority to CZ19982652A priority patent/CZ289268B6/cs
Priority to EE9800259A priority patent/EE03529B1/xx
Priority to ES97905057T priority patent/ES2180932T3/es
Priority to HU9900987A priority patent/HUP9900987A3/hu
Priority to EP97905057A priority patent/EP0885230B1/en
Priority to AU18753/97A priority patent/AU718361B2/en
Priority to CA002247513A priority patent/CA2247513C/en
Priority to RU98117449/04A priority patent/RU2165935C2/ru
Priority to NZ331126A priority patent/NZ331126A/en
Priority to IL12585697A priority patent/IL125856A/xx
Priority to AT97905057T priority patent/ATE221071T1/de
Priority to BRPI9707622-8A priority patent/BR9707622B1/pt
Priority to KR1019980706498A priority patent/KR100497906B1/ko
Priority to UA98084449A priority patent/UA49005C2/uk
Priority to DE69714220T priority patent/DE69714220T2/de
Priority to DK97905057T priority patent/DK0885230T3/da
Priority to PT97905057T priority patent/PT885230E/pt
Priority to PCT/EP1997/000786 priority patent/WO1997031003A1/en
Priority to SK1127-98A priority patent/SK283217B6/sk
Publication of ITMI960338A1 publication Critical patent/ITMI960338A1/it
Publication of IT1282673B1 publication Critical patent/IT1282673B1/it
Application granted granted Critical
Priority to US09/643,256 priority patent/US6306868B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT96MI000338A 1996-02-23 1996-02-23 Derivati della camptotecina e loro uso come agenti antitumorali IT1282673B1 (it)

Priority Applications (24)

Application Number Priority Date Filing Date Title
IT96MI000338A IT1282673B1 (it) 1996-02-23 1996-02-23 Derivati della camptotecina e loro uso come agenti antitumorali
SK1127-98A SK283217B6 (sk) 1996-02-23 1997-02-19 Kamptotecínové deriváty, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
RU98117449/04A RU2165935C2 (ru) 1996-02-23 1997-02-19 Производные камптотецина, их n-оксиды, способы их получения и фармацевтическая композиция
AT97905057T ATE221071T1 (de) 1996-02-23 1997-02-19 Campotecinderivate und ihre verwendung als antitumormittel
US09/125,512 US6130227A (en) 1996-02-23 1997-02-19 7-Substituted camptothecin derivatives and methods for inhibiting the growth of tumor cells therewith
CZ19982652A CZ289268B6 (cs) 1996-02-23 1997-02-19 Deriváty camptothecinu, způsob výroby a farmaceutický prostředek
EE9800259A EE03529B1 (et) 1996-02-23 1997-02-19 Kamptotetsiinderivaadid, nende valmistamise meetod ja kasutamine kasvajavastaste ainetena
ES97905057T ES2180932T3 (es) 1996-02-23 1997-02-19 Derivados de camptotecina y su uso como agentes antitumorales.
HU9900987A HUP9900987A3 (en) 1996-02-23 1997-02-19 Camptothecin derivatives process for their preparation, use thereof as antitumor agents and pharmaceutical compositions containing them
EP97905057A EP0885230B1 (en) 1996-02-23 1997-02-19 Camptothecin derivatives and the use thereof as antitumor agents
AU18753/97A AU718361B2 (en) 1996-02-23 1997-02-19 Camptothecin derivatives and the use thereof as antitumor agents
CA002247513A CA2247513C (en) 1996-02-23 1997-02-19 Camptothecin derivatives and the use thereof as antitumor agents
JP52979197A JP4171527B2 (ja) 1996-02-23 1997-02-19 カンプトテシン誘導体及び抗腫瘍剤としてのその利用
NZ331126A NZ331126A (en) 1996-02-23 1997-02-19 Camptothecin derivatives and the use thereof as antitumor agents
IL12585697A IL125856A (en) 1996-02-23 1997-02-19 7-substituted camptothecin derivatives, their preparation and pharmaceutical compositions containing them
CN97192493A CN1107677C (zh) 1996-02-23 1997-02-19 喜树碱衍生物和制备方法及其作为抗肿瘤剂的应用
BRPI9707622-8A BR9707622B1 (pt) 1996-02-23 1997-02-19 derivados de camptotecina, bem como composição farmacêutica compreendendo os mesmos.
KR1019980706498A KR100497906B1 (ko) 1996-02-23 1997-02-19 캄토테신유도체와이를활성성분으로하는항암제
UA98084449A UA49005C2 (uk) 1996-02-23 1997-02-19 Похідні камптотецину (варіанти), спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
DE69714220T DE69714220T2 (de) 1996-02-23 1997-02-19 Campotecinderivate und ihre verwendung als antitumormittel
DK97905057T DK0885230T3 (da) 1996-02-23 1997-02-19 Camptothecinderivater og deres anvendelse som antitumormidler
PT97905057T PT885230E (pt) 1996-02-23 1997-02-19 Derivados de camptotecina e sua utilizacao como agentes antitumorais
PCT/EP1997/000786 WO1997031003A1 (en) 1996-02-23 1997-02-19 Camptothecin derivatives and the use thereof as antitumor agents
US09/643,256 US6306868B1 (en) 1996-02-23 2000-08-22 Methods for inhibiting the growth of tumors with 7-substituted camptothecin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000338A IT1282673B1 (it) 1996-02-23 1996-02-23 Derivati della camptotecina e loro uso come agenti antitumorali

Publications (3)

Publication Number Publication Date
ITMI960338A0 ITMI960338A0 (OSRAM) 1996-02-23
ITMI960338A1 ITMI960338A1 (it) 1997-08-23
IT1282673B1 true IT1282673B1 (it) 1998-03-31

Family

ID=11373368

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI000338A IT1282673B1 (it) 1996-02-23 1996-02-23 Derivati della camptotecina e loro uso come agenti antitumorali

Country Status (22)

Country Link
US (2) US6130227A (OSRAM)
EP (1) EP0885230B1 (OSRAM)
JP (1) JP4171527B2 (OSRAM)
KR (1) KR100497906B1 (OSRAM)
CN (1) CN1107677C (OSRAM)
AT (1) ATE221071T1 (OSRAM)
AU (1) AU718361B2 (OSRAM)
BR (1) BR9707622B1 (OSRAM)
CZ (1) CZ289268B6 (OSRAM)
DE (1) DE69714220T2 (OSRAM)
DK (1) DK0885230T3 (OSRAM)
EE (1) EE03529B1 (OSRAM)
ES (1) ES2180932T3 (OSRAM)
HU (1) HUP9900987A3 (OSRAM)
IL (1) IL125856A (OSRAM)
IT (1) IT1282673B1 (OSRAM)
NZ (1) NZ331126A (OSRAM)
PT (1) PT885230E (OSRAM)
RU (1) RU2165935C2 (OSRAM)
SK (1) SK283217B6 (OSRAM)
UA (1) UA49005C2 (OSRAM)
WO (1) WO1997031003A1 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69900689T2 (de) * 1998-06-26 2002-08-29 Quanam Medical Corp., Santa Clara Topoisomerase inhibitoren zur restenose-prevention
US7105492B2 (en) 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
DK1044977T3 (da) 1999-03-09 2002-07-08 Sigma Tau Ind Farmaceuti Camptothecinderivater med antitumoraktivitet
AR025587A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
US6950757B2 (en) * 2001-04-11 2005-09-27 Emerald Biostructures, Inc. Screening methods for identifying ligands
RU2319482C2 (ru) * 2001-11-23 2008-03-20 Чугаи Сейяку Кабусики Кайся Способ идентификации противоопухолевых целевых ферментов
BR0308133A (pt) * 2002-03-01 2005-01-04 Pharmacia Italia Spa Forma polimórfica cristalina de cloridrato de irinotecan
TW200306314A (en) * 2002-04-16 2003-11-16 Tanabe Seiyaku Co Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
US7067666B2 (en) * 2003-06-27 2006-06-27 Research Triangle Institute 7-substituted camptothecin and camptothecin analogs and methods for producing the same
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
TWI333492B (en) * 2003-11-12 2010-11-21 Smithkline Beecham Cork Ltd Crystalline topotecan hydrochloride product and preparation thereof
BRPI0620209A2 (pt) 2005-12-21 2011-11-01 Sigma Tau Ind Famaceutiche Riunite S P A tratamento de tumores resistentes a fármacos
WO2007095389A2 (en) * 2006-02-17 2007-08-23 Novacea, Inc. Treatment of hyperproliferative diseases with camptothecine n-oxide and analogs
CN101033230B (zh) * 2006-03-10 2010-12-08 中国科学院上海药物研究所 一类喜树碱衍生物及其应用
ITMI20061474A1 (it) * 2006-07-26 2008-01-27 Indena Spa Derivati della camptotecina ad attivita antitumorale
CN102731516B (zh) * 2011-04-07 2014-07-02 宁波天衡药业股份有限公司 一类具有抗肿瘤活性的喜树碱衍生物
CN104774209B (zh) * 2014-01-15 2018-06-19 上海海和药物研究开发有限公司 一种9-烯丙基喜树碱衍生物的合成方法
WO2023030364A1 (zh) * 2021-09-01 2023-03-09 上海弼领生物技术有限公司 一种喜树碱类化合物、其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399282A (en) * 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
JPS58154582A (ja) * 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
US5459269A (en) * 1992-06-18 1995-10-17 North Carolina State University 14-halo-camptothecins
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
WO1998007727A1 (en) * 1996-08-19 1998-02-26 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives

Also Published As

Publication number Publication date
NZ331126A (en) 2000-02-28
IL125856A (en) 2001-08-26
HUP9900987A3 (en) 2000-01-28
AU718361B2 (en) 2000-04-13
DE69714220D1 (de) 2002-08-29
ITMI960338A0 (OSRAM) 1996-02-23
UA49005C2 (uk) 2002-09-16
ATE221071T1 (de) 2002-08-15
EP0885230A1 (en) 1998-12-23
JP2000505448A (ja) 2000-05-09
DE69714220T2 (de) 2002-11-14
US6306868B1 (en) 2001-10-23
RU2165935C2 (ru) 2001-04-27
CN1107677C (zh) 2003-05-07
AU1875397A (en) 1997-09-10
HUP9900987A2 (hu) 1999-08-30
CZ289268B6 (cs) 2001-12-12
CZ265298A3 (cs) 1999-01-13
JP4171527B2 (ja) 2008-10-22
ITMI960338A1 (it) 1997-08-23
ES2180932T3 (es) 2003-02-16
BR9707622A (pt) 1999-07-27
BR9707622B1 (pt) 2010-08-10
SK112798A3 (en) 1999-01-11
SK283217B6 (sk) 2003-03-04
CN1211987A (zh) 1999-03-24
KR19990087110A (ko) 1999-12-15
PT885230E (pt) 2002-12-31
EE03529B1 (et) 2001-10-15
US6130227A (en) 2000-10-10
KR100497906B1 (ko) 2006-03-09
EP0885230B1 (en) 2002-07-24
WO1997031003A1 (en) 1997-08-28
IL125856A0 (en) 1999-04-11
EE9800259A (et) 1999-02-15
DK0885230T3 (da) 2002-11-18

Similar Documents

Publication Publication Date Title
IT1282673B1 (it) Derivati della camptotecina e loro uso come agenti antitumorali
NO950879L (no) 3-fenylpyrrolidin-derivater
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
TR200002759T2 (tr) Bacak uyuşması sendromunun tedavisinde kabergolin kullanımı.
TR200002355T2 (tr) 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
TR200909479T2 (tr) Sinerjistik kombinasyon.
AR023777A1 (es) Nuevos compuestos
PT998460E (pt) Novos derivados de tetrazole
EE200200064A (et) Arüülmetüülkarbonüülaminotiasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena
TR200102928T2 (tr) Farmasötik bileşikler.
NO20020684L (no) 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler
HUP0301320A2 (hu) Glikopeptid-foszfonát-származékok
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
BR0007864A (pt) Composto, e, uso de um composto
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
DK1015437T3 (da) Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler
BR0011261B1 (pt) composiÇço oral compreendendo perlita, e, uso de perlita.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
IT1317049B1 (it) Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv.
ZA200107985B (en) Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa.
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
FI20002257L (fi) Järjestelmä työntekijän tms. paikallistamiseksi ja työn valvomiseksi
DK1087973T3 (da) Imidazotriazolopyrimidiner som lægemiddel med adenosinantagonist effekt
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
BR0009102A (pt) Compostos tiofenoetil tiouréia e uso no tratamento do hiv

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970529